Gadolinium-based nanoscale MRI contrast agents for tumor imaging-Reference-Cited by-同舟云学术

Gadolinium-based nanoscale MRI contrast agents for tumor imaging

Published:2017 Issue:19 Volume:5 Page:3431-3461
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Cao Yi¹²³⁴⁵^ORCID,Xu Lijun¹²³⁴⁵^ORCID,Kuang Ye¹²³⁴⁵,Xiong Dangsheng⁶⁷⁸⁹^ORCID,Pei Renjun¹²³⁴⁵^ORCID

Affiliation:

1. CAS Key Laboratory of Nano-Bio Interface

2. Division of Nanobiomedicine

3. Suzhou Institute of Nano-Tech and Nano-Bionics

4. Chinese Academy of Sciences

5. Suzhou 215123

6. School of Materials Science and Engineering

7. Nanjing University of Science and Technology

8. Nanjing 210094

9. China

Abstract

Gadolinium-based nanoscale MRI CAs have been considered as a promising nanoplatform for tumor diagnosis, due to their favorable capability of enhancing the longitudinal relaxivity (r₁) of individual gadolinium ions, delivering to the region of interest a large number of gadolinium ions, and incorporating different functionalities.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2017/TB/C7TB00382J

Reference164 articles.

1. Nanostructured T1 MRI contrast agents

2. Molecular Imaging in Cancer

3. Magnetic resonance imaging contrast agents: Overview and perspectives